142 related articles for article (PubMed ID: 11306469)
1. Characterization of the biological activity of gamma-glutamyl-Se-methylselenocysteine: a novel, naturally occurring anticancer agent from garlic.
Dong Y; Lisk D; Block E; Ip C
Cancer Res; 2001 Apr; 61(7):2923-8. PubMed ID: 11306469
[TBL] [Abstract][Full Text] [Related]
2. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
Ip C; Thompson HJ; Ganther HE
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):49-54. PubMed ID: 10667463
[TBL] [Abstract][Full Text] [Related]
3. Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland.
Ip C; Dong Y
Anticancer Res; 2001; 21(2A):863-7. PubMed ID: 11396176
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.
Ip C; Thompson HJ; Zhu Z; Ganther HE
Cancer Res; 2000 Jun; 60(11):2882-6. PubMed ID: 10850432
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.
Unni E; Kittrell FS; Singh U; Sinha R
Breast Cancer Res; 2004; 6(5):R586-92. PubMed ID: 15318939
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a field effect associated with mammary cancer chemoprevention by methylseleninic acid.
Dong Y; Ip C; Ganther H
Anticancer Res; 2002; 22(1A):27-32. PubMed ID: 12017302
[TBL] [Abstract][Full Text] [Related]
7. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
8. Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention.
Lu J; Pei H; Ip C; Lisk DJ; Ganther H; Thompson HJ
Carcinogenesis; 1996 Sep; 17(9):1903-7. PubMed ID: 8824512
[TBL] [Abstract][Full Text] [Related]
9. Chemical form of selenium, critical metabolites, and cancer prevention.
Ip C; Hayes C; Budnick RM; Ganther HE
Cancer Res; 1991 Jan; 51(2):595-600. PubMed ID: 1824684
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
11. Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile.
Ip C; Lisk DJ; Ganther H; Thompson HJ
Anticancer Res; 1997; 17(5A):3195-9. PubMed ID: 9413148
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat.
Ip C; Zhu Z; Thompson HJ; Lisk D; Ganther HE
Anticancer Res; 1999; 19(4B):2875-80. PubMed ID: 10652567
[TBL] [Abstract][Full Text] [Related]
13. Se-methylselenocysteine alters collagen gene and protein expression in human prostate cells.
Hurst R; Elliott RM; Goldson AJ; Fairweather-Tait SJ
Cancer Lett; 2008 Sep; 269(1):117-26. PubMed ID: 18514395
[TBL] [Abstract][Full Text] [Related]
14. Se-methylselenocysteine sensitized TRAIL-mediated apoptosis via down-regulation of Bcl-2 expression.
Lee JT; Lee TJ; Park JW; Kwon TK
Int J Oncol; 2009 May; 34(5):1455-60. PubMed ID: 19360359
[TBL] [Abstract][Full Text] [Related]
15. Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
Medina D; Thompson H; Ganther H; Ip C
Nutr Cancer; 2001; 40(1):12-7. PubMed ID: 11799917
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of mammary cancer chemoprevention by organoselenium compounds.
El-Bayoumy K; Sinha R
Mutat Res; 2004 Jul; 551(1-2):181-97. PubMed ID: 15225592
[TBL] [Abstract][Full Text] [Related]
17. Chemical speciation influences comparative activity of selenium-enriched garlic and yeast in mammary cancer prevention.
Ip C; Birringer M; Block E; Kotrebai M; Tyson JF; Uden PC; Lisk DJ
J Agric Food Chem; 2000 Jun; 48(6):2062-70. PubMed ID: 10888499
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray.
El-Bayoumy K; Narayanan BA; Desai DH; Narayanan NK; Pittman B; Amin SG; Schwartz J; Nixon DW
Carcinogenesis; 2003 Sep; 24(9):1505-14. PubMed ID: 12844480
[TBL] [Abstract][Full Text] [Related]
19. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents.
Ip C; Lisk DJ; Ganther HE
Anticancer Res; 1998; 18(6A):4019-25. PubMed ID: 9891440
[TBL] [Abstract][Full Text] [Related]
20. Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis.
Ip C; Lisk DJ; Thompson HJ
Carcinogenesis; 1996 Sep; 17(9):1979-82. PubMed ID: 8824523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
